Ignite Creation Date:
2024-05-06 @ 3:03 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04502394
Status:
UNKNOWN
Last Update Posted:
2022-08-04
First Post:
2020-07-27
Brief Title:
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With RR DLBCL or RR CLL
Sponsor:
Kartos Therapeutics Inc
Organization:
Kartos Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-23
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-03
Completion Date Type:
ESTIMATED
First Submit Date:
2020-07-27
First Submit QC Date:
August 5 2020
Study First Post Date:
2020-08-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-03
Last Update Post Date:
2022-08-04
Last Update Post Date Type:
ACTUAL